OxymiRs in cutaneous development, wound repair and regeneration

Seminars in Cell and Developmental Biology

Volumn 23, Issue 9, 2012, Pages 971-980

  Sen, Chandan K ^a   Roy, Sashwati ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Skin; Wound

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ARACHIDONATE 5 LIPOXYGENASE; CYTOCHROME C OXIDASE; EARLY GROWTH RESPONSE FACTOR 3; ERYTHROPOIETIN; GELATINASE A; LEUKOTRIENE; MICRORNA; MICRORNA 107; MICRORNA 210; MICRORNA 31; OXYMICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMAD ANCHOR FOR RECEPTOR ACTIVATION; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

CANCER CELL CULTURE; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; CELL MIGRATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC WOUND; CUTANEOUS DEVELOPMENT; CYTOLOGY; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC CODE; HUMAN; HYPOXIA; IN VITRO STUDY; ISCHEMIA; MORPHOLOGY; NONHUMAN; OOCYTE DEVELOPMENT; ORGANOGENESIS; OXYGEN SENSING; OXYGEN TOXICITY; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; REGENERATION; RESPIRATORY CHAIN; REVIEW; SEQUENCE ANALYSIS; STEM CELL; TISSUE OXYGENATION; WOUND HEALING;

EID: 84870569076     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.09.012     Document Type: Review

References (183)

1. Chan Y.C., Banerjee J., Choi S.Y., Sen C.K. miR-210: the master hypoxamir. Microcirculation 2012, 19:215-223.
2. Devlin C., Greco S., Martelli F. Ivan M. miR-210: More than a silent player in hypoxia. IUBMB Life 2011, 63:94-100.
3. McCormick R., Buffa F.M., Ragoussis J., Harris A.L. The role of hypoxia regulated microRNAs in cancer. Current Topics in Microbiology and Immunology 2010, 345:47-70.
4. Huang X., Le Q.T., Giaccia A.J. miR-210-micromanager of the hypoxia pathway. Trends in Molecular Medicine 2010, 16:230-237.
5. Ivan M., Harris A.L., Martelli F., Kulshreshtha R. Hypoxia response and microRNAs: no longer two separate worlds. Journal of Cellular and Molecular Medicine 2008, 12:1426-1431.
6. Kulshreshtha R., Ferracin M., Negrini M., Calin G.A., Davuluri R.V., Ivan M. Regulation of microRNA expression: the hypoxic component. Cell Cycle 2007, 6:1426-1431.
7. Dong J., Carey W.A., Abel S., Collura C., Jiang G., Tomaszek S., et al. microRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia. BMC Genomics 2012, 13:204.
8. Zhang X., Peng W., Zhang S., Wang C., He X., Zhang Z., et al. MicroRNA expression profile in hyperoxia-exposed newborn mice during the development of bronchopulmonary dysplasia. Respiratory Care 2011, 56:1009-1015.
9. Aragones J., Fraisl P., Baes M., Carmeliet P. Oxygen sensors at the crossroad of metabolism. Cell Metabolism 2009, 9:11-22.
10. Boutilier R.G., St-Pierre J. Surviving hypoxia without really dying. Comparative Biochemistry and Physiology. Part A: Molecular and Integrative Physiology 2000, 126:481-490.
11. Fandrey J. Hypoxia-inducible gene expression. Respiration Physiology 1995, 101:1-10.
12. Semenza G.L. Hypoxia-inducible factors in physiology and medicine. Cell 2012, 148:399-408.
13. Giannakakis A., Sandaltzopoulos R., Greshock J., Liang S., Huang J., Hasegawa K., et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biology and Therapy 2008, 7:255-264.
14. Crosby M.E., Devlin C.M., Glazer P.M., Calin G.A., Ivan M. Emerging roles of microRNAs in the molecular responses to hypoxia. Current Pharmaceutical Design 2009, 15:3861-3866.
15. Pocock R. Invited review: decoding the microRNA response to hypoxia. Pflugers Archiv 2011, 461:307-315.
16. Dejean E., Renalier M.H., Foisseau M., Agirre X., Joseph N., de Paiva G.R., et al. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia 2011, 25:1882-1890.
17. Taguchi A., Yanagisawa K., Tanaka M., Cao K., Matsuyama Y., Goto H., et al. Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Research 2008, 68:5540-5545.
18. Brock M., Samillan V.J., Trenkmann M., Schwarzwald C., Ulrich S., Gay R.E., et al. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. European Heart Journal 2012, [Epub ahead of print].
19. Frank D., Gantenberg J., Boomgaarden I., Kuhn C., Will R., Jarr K.U., et al. MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis involving its novel target Egln3/PHD3. Journal of Molecular and Cellular Cardiology 2012, 52:711-717.
20. Kang S.G., Lee W.H., Lee Y.H., Lee Y.S., Kim S.G. Hypoxia-inducible factor-1alpha inhibition by a pyrrolopyrazine metabolite of oltipraz as a consequence of microRNAs 199a-5p and 20a induction. Carcinogenesis 2012, 33:661-669.
21. Lin S.C., Wang C.C., Wu M.H., Yang S.H., Li Y.H., Tsai S.J. Hypoxia-induced microRNA-20a expression increases ERK phosphorylation and angiogenic gene expression in endometriotic stromal cells. Journal of Clinical Endocrinology and Metabolism 2012, 97(8):E1515-E1523.
22. Lei Z., Li B., Yang Z., Fang H., Zhang G.M., Feng Z.H., et al. Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE 2009, 4:e7629.
23. Cascio S., D'Andrea A., Ferla R., Surmacz E., Gulotta E., Amodeo V., et al. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. Journal of Cellular Physiology 2010, 224:242-249.
24. Dong S., Cheng Y., Yang J., Li J., Liu X., Wang X., et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. Journal of Biological Chemistry 2009, 284:29514-29525.
25. Caruso P., MacLean M.R., Khanin R., McClure J., Soon E., Southgate M., et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:716-723.
26. Cheng Y., Zhu P., Yang J., Liu X., Dong S., Wang X., et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovascular Research 2010, 87:431-439.
27. Gee H.E., Camps C., Buffa F.M., Patiar S., Winter S.C., Betts G., et al. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010, 116:2148-2158.
28. Loayza-Puch F., Yoshida Y., Matsuzaki T., Takahashi C., Kitayama H., Noda M. Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs. Oncogene 2010, 29:2638-2648.
29. Neal C.S., Michael M.Z., Rawlings L.H., Van der Hoek M.B., Gleadle J.M. The VHL-dependent regulation of microRNAs in renal cancer. BMC Medicine 2010, 8:64.
30. Sarkar J., Gou D., Turaka P., Viktorova E., Ramchandran R., Raj J.U. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. American Journal of Physiology - Lung Cellular and Molecular Physiology 2010, 299:L861-L871.
31. Sayed D., He M., Hong C., Gao S., Rane S., Yang Z., et al. microRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. Journal of Biological Chemistry 2010, 285:20281-20290.
32. Baggish A.L., Hale A., Weiner R.B., Lewis G.D., Systrom D., Wang F., et al. Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. Journal of Physiology 2011, 589:3983-3994.
33. Gorospe M., Tominaga K., Wu X., Fahling M., Ivan M. Post-transcriptional control of the hypoxic response by RNA-binding proteins and microRNAs. Frontiers in Molecular Neuroscience 2011, 4:7.
34. Liu L.Z., Li C., Chen Q., Jing Y., Carpenter R., Jiang Y., et al. miR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS ONE 2011, 6:e19139.
35. Polytarchou C., Iliopoulos D., Hatziapostolou M., Kottakis F., Maroulakou I., Struhl K., et al. Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation. Cancer Research 2011, 71:4720-4731.
36. Wang M., Li W., Chang G.Q., Ye C.S., Ou J.S., Li X.X., et al. microRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:2044-2053.
37. Parikh V.N., Jin R.C., Rabello S., Gulbahce N., White K., Hale A., et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 2012, 125:1520-1532.
38. Pullamsetti S.S., Doebele C., Fischer A., Savai R., Kojonazarov B., Dahal B.K., et al. Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 2012, 185:409-419.
39. Voellenkle C., Rooij J., Guffanti A., Brini E., Fasanaro P., Isaia E., et al. Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. RNA 2012, 18:472-484.
40. Xu X., Kriegel A.J., Liu Y., Usa K., Mladinov D., Liu H., et al. Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney International 2012.
41. Yang S., Banerjee S., Freitas A., Cui H., Xie N., Abraham E., et al. miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. American Journal of Physiology - Lung Cellular and Molecular Physiology 2012, 302:L521-L529.
42. Yamakuchi M., Yagi S., Ito T., Lowenstein C.J. microRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS ONE 2011, 6:e20291.
43. He H.C., Zhu J.G., Chen X.B., Chen S.M., Han Z.D., Dai Q.S., et al. microRNA-23b downregulates peroxiredoxin III in human prostate cancer. FEBS Letters 2012, 586:2451-2458.
44. Kulshreshtha R., Ferracin M., Wojcik S.E., Garzon R., Alder H., Agosto-Perez F.J., et al. A microRNA signature of hypoxia. Molecular and Cellular Biology 2007, 27:1859-1867.
45. Lin Q., Gao Z., Alarcon R.M., Ye J., Yun Z. A role of miR-27 in the regulation of adipogenesis. FEBS Journal 2009, 276:2348-2358.
46. Peng H., Hamanaka R.B., Katsnelson J., Hao L.L., Yang W., Chandel N.S., et al. microRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism. FASEB Journal 2012, 26(8):3140-3147.
47. Du R., Sun W., Xia L., Zhao A., Yu Y., Zhao L., et al. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS ONE 2012, 7:e30771.
48. Donker R.B., Mouillet J.F., Nelson D.M., Sadovsky Y. The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts. Molecular Human Reproduction 2007, 13:273-279.
49. Cao P., Deng Z., Wan M., Huang W., Cramer S.D., Xu J., et al. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Molecular Cancer 2010, 9:108.
50. Yamakuchi M., Lotterman C.D., Bao C., Hruban R.H., Karim B., Mendell J.T., et al. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:6334-6339.
51. Shi Z.M., Wang J., Yan Z., You Y.P., Li C.Y., Qian X., et al. MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLoS ONE 2012, 7:e32709.
52. Saito K., Kondo E., Matsushita M. microRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6. Nucleic Acids Research 2011, 39:6086-6099.
53. Song T., Zhang X., Wang C., Wu Y., Cai W., Gao J., et al. MiR-138 suppresses expression of hypoxia-inducible factor 1alpha (HIF-1alpha) in clear cell renal cell carcinoma 786-O cells. Asian Pacific Journal of Cancer Prevention 2011, 12:1307-1311.
54. Caruso P., Dempsie Y., Stevens H.C., McDonald R.A., Long L., Lu R., et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circulation Research 2012, 111:290-300.
55. Dunwoodie S.L. The role of hypoxia in development of the Mammalian embryo. Developmental Cell 2009, 17:755-773.
56. Yeligar S., Tsukamoto H., Kalra V.K. Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199. Journal of Immunology 2009, 183:5232-5243.
57. Juan D., Alexe G., Antes T., Liu H., Madabhushi A., Delisi C., et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology 2010, 75:835-841.
58. Jung M., Schaefer A., Steiner I., Kempkensteffen C., Stephan C., Erbersdobler A., et al. Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clinical Chemistry 2010, 56:998-1006.
59. Babar I.A., Czochor J., Steinmetz A., Weidhaas J.B., Glazer P.M., Slack F.J. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biology and Therapy 2011, 12:908-914.
60. Bruning U., Cerone L., Neufeld Z., Fitzpatrick S.F., Cheong A., Scholz C.C., et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Molecular and Cellular Biology 2011, 31:4087-4096.
61. Lages E., Guttin A., El Atifi M., Ramus C., Ipas H., Dupre I., et al. MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes. PLoS ONE 2011, 6:e20600.
62. Rink C., Khanna S. MicroRNA in ischemic stroke etiology and pathology. Physiological Genomics 2011, 43:521-528.
63. Rane S., He M., Sayed D., Vashistha H., Malhotra A., Sadoshima J., et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circulation Research 2009, 104:879-886.
64. Duan Q., Wang X., Gong W., Ni L., Chen C., He X., et al. ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS ONE 2012, 7:e31518.
65. Jia X.Q., Cheng H.Q., Qian X., Bian C.X., Shi Z.M., Zhang J.P., et al. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma. Cell Biochemistry and Biophysics 2012, 62:237-244.
66. Mizuno S., Bogaard H.J., Gomez-Arroyo J., Alhussaini A., Kraskauskas D., Cool C.D., et al. MicroRNA-199a-5p is associated with hypoxia inducible factor-1alpha expression in the lung from COPD patients. Chest 2012.
67. Chan Y.C., Khanna S., Roy S., Sen C.K. miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. Journal of Biological Chemistry 2011, 286:2047-2056.
68. Chan Y.C., Roy S., Khanna S., Sen C.K. Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arteriosclerosis, Thrombosis, and Vascular Biology 2012, 32:1372-1382.
69. Mouillet J.F., Chu T., Nelson D.M., Mishima T., Sadovsky Y. MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB Journal 2010, 24:2030-2039.
70. Camps C., Buffa F.M., Colella S., Moore J., Sotiriou C., Sheldon H., et al. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clinical Cancer Research 2008, 14:1340-1348.
71. Corn P.G. Hypoxic regulation of miR-210: shrinking targets expand HIF-1's influence. Cancer Biology and Therapy 2008, 7:265-267.
72. Fasanaro P., D'Alessandra Y., Di Stefano V., Melchionna R., Romani S., Pompilio G., et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. Journal of Biological Chemistry 2008, 283:15878-15883.
73. Galanis A., Pappa A., Giannakakis A., Lanitis E., Dangaj D., Sandaltzopoulos R. Reactive oxygen species and HIF-1 signalling in cancer. Cancer Letters 2008, 266:12-20.
74. Pulkkinen K., Malm T., Turunen M., Koistinaho J., Yla-Herttuala S. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Letters 2008, 582:2397-2401.
75. Chan S.Y., Zhang Y.Y., Hemann C., Mahoney C.E., Zweier J.L., Loscalzo J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metabolism 2009, 10:273-284.
76. Fasanaro P., Greco S., Lorenzi M., Pescatori M., Brioschi M., Kulshreshtha R., et al. An integrated approach for experimental target identification of hypoxia-induced miR-210. Journal of Biological Chemistry 2009, 284:35134-35143.
77. Huang X., Ding L., Bennewith K.L., Tong R.T., Welford S.M., Ang K.K., et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Molecular Cell 2009, 35:856-867.
78. Kim H.W., Haider H.K., Jiang S., Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. Journal of Biological Chemistry 2009, 284:33161-33168.
79. Mathew L.K. Simon MC. mir-210: a sensor for hypoxic stress during tumorigenesis. Molecular Cell 2009, 35:737-738.
80. Zhang Z., Sun H., Dai H., Walsh R.M., Imakura M., Schelter J., et al. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 2009, 8:2756-2768.
81. Chan S.Y., Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010, 9:1072-1083.
82. Chen Z., Li Y., Zhang H., Huang P., Luthra R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 2010, 29:4362-4368.
83. Favaro E., Ramachandran A., McCormick R., Gee H., Blancher C., Crosby M., et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS ONE 2010, 5:e10345.
84. Ho A.S., Huang X., Cao H., Christman-Skieller C., Bennewith K., Le Q.T., et al. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Translational Oncology 2010, 3:109-113.
85. Hu S., Huang M., Li Z., Jia F., Ghosh Z., Lijkwan M.A., et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010, 122:S124-S131.
86. Kelly T.J., Souza A.L., Clish C.B., Puigserver P. A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Molecular and Cellular Biology 2011, 31:2696-2706.
87. Lee D.C., Romero R., Kim J.S., Tarca A.L., Montenegro D., Pineles B.L., et al. miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies. American Journal of Pathology 2011, 179:590-602.
88. Mutharasan R.K., Nagpal V., Ichikawa Y. Ardehali H. microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. American Journal of Physiology - Heart and Circulatory Physiology 2011, 301:H1519-H1530.
89. Nakada C., Tsukamoto Y., Matsuura K., Nguyen T.L., Hijiya N., Uchida T., et al. Overexpression of miR-210, a downstream target of HIF1alpha, causes centrosome amplification in renal carcinoma cells. Journal of Pathology 2011, 224:280-288.
90. Puissegur M.P., Mazure N.M., Bertero T., Pradelli L., Grosso S., Robbe-Sermesant K., et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death and Differentiation 2011, 18:465-478.
91. Quero L., Dubois L., Lieuwes N.G., Hennequin C., Lambin P. miR-210 as a marker of chronic hypoxia, but not a therapeutic target in prostate cancer. Radiotherapy and Oncology 2011, 101:203-208.
92. Zeng L., Liu J., Wang Y., Wang L., Weng S., Tang Y., et al. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Frontiers in Bioscience (Elite Edition) 2011, 3:1265-1272.
93. Biswas S., Roy S., Banerjee J., Hussain S.R., Khanna S., Meenakshisundaram G., et al. Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:6976-6981.
94. Guo L., Qiu Z., Wei L., Yu X., Gao X., Jiang S., et al. The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-alpha1C. Hypertension 2012, 59:1006-1013.
95. Crosby M.E., Kulshreshtha R., Ivan M., Glazer P.M. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Research 2009, 69:1221-1229.
96. Chang Y., Yan W., He X., Zhang L., Li C., Huang H., et al. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 2012, 143:177-187. e8.
97. Kawahigashi Y., Mishima T., Mizuguchi Y., Arima Y., Yokomuro S., Kanda T., et al. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. Journal of Nippon Medical School 2009, 76:188-197.
98. Ghosh G., Subramanian I.V., Adhikari N., Zhang X., Joshi H.P., Basi D., et al. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. Journal of Clinical Investigation 2010, 120:4141-4154.
99. Wang K., Long B., Jiao J.Q., Wang J.X., Liu J.P., Li Q., et al. miR-484 regulates mitochondrial network through targeting Fis1. Nature Communications 2012, 3:781.
100. Hwang-Verslues W.W., Chang P.H., Wei P.C., Yang C.Y., Huang C.K., Kuo W.H., et al. miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. Oncogene 2011, 30:2463-2474.
101. Cha S.T., Chen P.S., Johansson G., Chu C.Y., Wang M.Y., Jeng Y.M., et al. MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Research 2010, 70:2675-2685.
102. Hebert C., Norris K., Scheper M.A., Nikitakis N., Sauk J.J. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 2007, 6:5.
103. Hua Z., Lv Q., Ye W., Wong C.K., Cai G., Gu D., et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 2006, 1:e116.
104. Gao P., Sun L., He X., Cao Y., F Zhang H. MicroRNAs the Warburg effect: new players in an old arena. Current Gene Therapy 2012, 12:285-291.
105. Tang H., Lee M., Sharpe O., Salamone L., Noonan E.J., Hoang C.D., et al. Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems. FASEB Journal 2012.
106. Ghosh A.K., Shanafelt T.D., Cimmino A., Taccioli C., Volinia S., Liu C.G., et al. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 2009, 113:5568-5574.
107. Liu C.J., Tsai M.M., Hung P.S., Kao S.Y., Liu T.Y., Wu K.J., et al. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Research 2010, 70:1635-1644.
108. Gonsalves C.S., Kalra V.K. Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF-1alpha and NF-kappaB and microRNAs 135a and 199a-5p. Journal of Immunology 2010, 184:3878-3888.
109. Bartels H., Baumann F. Metabolic rate of early embryos (4-22 somites) at varying oxygen pressures. Respiration Physiology 1972, 16:1-15.
110. New D.A., Coppola P.T. Effects of different oxygen concentrations on the development of rat embryos in culture. Journal of Reproduction and Fertility 1970, 21:109-118.
111. Auerbach S., Brinster R.L. Effect of oxygen concentration on the development of two-cell mouse embryos. Nature 1968, 217:465-466.
112. Wale P.L., Gardner D.K. Time-lapse analysis of mouse embryo development in oxygen gradients. Reproductive Biomedicine Online 2010, 21:402-410.
113. Umaoka Y., Noda Y., Narimoto K., Mori T. Effects of oxygen toxicity on early development of mouse embryos. Molecular Reproduction and Development 1992, 31:28-33.
114. Sapunar D., Saraga-Babic M., Peruzovic M., Marusic M. Effects of hyperbaric oxygen on rat embryos. Biology of the Neonate 1993, 63:360-369.
115. Ishibashi M., Akazawa S., Sakamaki H., Matsumoto K., Yamasaki H., Yamaguchi Y., et al. Oxygen-induced embryopathy and the significance of glutathione-dependent antioxidant system in the rat embryo during early organogenesis. Free Radical Biology and Medicine 1997, 22:447-454.
116. Kingdom J.C., Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997, 18:613-621. [discussion 23-6].
117. Nordstrom L., Arulkumaran S. Intrapartum fetal hypoxia and biochemical markers: a review. Obstetrical and Gynecological Survey 1998, 53:645-657.
118. Medina J.M. The role of lactate as an energy substrate for the brain during the early neonatal period. Biology of the Neonate 1985, 48:237-244.
119. Adolph E.F. Uptakes and uses of oxygen, from gametes to maturity: an overview. Respiration Physiology 1983, 53:135-160.
120. Semenza G.L., Agani F., Iyer N., Kotch L., Laughner E., Leung S., et al. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Annals of the New York Academy of Sciences 1999, 874:262-268.
121. Hooper S.B. Fetal metabolic responses to hypoxia. Reproduction, Fertility, and Development 1995, 7:527-538.
122. Simon M.C., Keith B. The role of oxygen availability in embryonic development and stem cell function. Nature Reviews Molecular Cell Biology 2008, 9:285-296.
123. Wale P.L., Gardner D.K. Oxygen regulates amino acid turnover and carbohydrate uptake during the preimplantation period of mouse embryo development. Biology of Reproduction 2012, 87:1-8.
124. Noda Y., Goto Y., Umaoka Y., Shiotani M., Nakayama T., Mori T. Culture of human embryos in alpha modification of Eagle's medium under low oxygen tension and low illumination. Fertility and Sterility 1994, 62:1022-1027.
125. Catt J.W., Henman M. Toxic effects of oxygen on human embryo development. Human Reproduction 2000, 15(Suppl. 2):199-206.
126. Bontekoe S., Mantikou E., van Wely M., Seshadri S., Repping S., Mastenbroek S. Low oxygen concentrations for embryo culture in assisted reproductive technologies. Cochrane Database of Systematic Reviews 2012, 7:CD008950.
127. Yi R., O'Carroll D., Pasolli H.A., Zhang Z., Dietrich F.S., Tarakhovsky A., et al. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nature Genetics 2006, 38:356-362.
128. Yi R., Pasolli H.A., Landthaler M., Hafner M., Ojo T., Sheridan R., et al. DGCR8-dependent microRNA biogenesis is essential for skin development. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:498-502.
129. Botchkareva N.V. MicroRNA/mRNA regulatory networks in the control of skin development and regeneration. Cell Cycle 2012, 11:468-474.
130. Hildebrand J., Rutze M., Walz N., Gallinat S., Wenck H., Deppert W., et al. A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. Journal of Investigative Dermatology 2011, 131:20-29.
131. Owens P., Han G., Li A.G., Wang X.J. The role of Smads in skin development. Journal of Investigative Dermatology 2008, 128:783-790.
132. Mizuno Y., Tokuzawa Y., Ninomiya Y., Yagi K., Yatsuka-Kanesaki Y., Suda T., et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Letters 2009, 583:2263-2268.
133. Botchkarev V.A., Sharov A.A. BMP signaling in the control of skin development and hair follicle growth. Differentiation 2004, 72:512-526.
134. Ahmed M.I., Mardaryev A.N., Lewis C.J., Sharov A.A., Botchkareva N.V. MicroRNA-21 is an important downstream component of BMP signalling in epidermal keratinocytes. Journal of Cell Science 2011, 124:3399-3404.
135. Aberdam D., Candi E., Knight R.A., Melino G. miRNAs, 'stemness' and skin. Trends in Biochemical Sciences 2008, 33:583-591.
136. Shilo S., Roy S., Khanna S., Sen C.K. MicroRNA in cutaneous wound healing: a new paradigm. DNA and Cell Biology 2007, 26:227-237.
137. Pastar I., Khan A.A., Stojadinovic O., Lebrun E.A., Medina M.C., Brem H., et al. Induction of specific micro Ribonucleic acids (miRNAs) inhibits cutaneous wound healing. Journal of Biological Chemistry 2012, 287:29324-29335.
138. Koster M.I. p63 in skin development and ectodermal dysplasias. Journal of Investigative Dermatology 2010, 130:2352-2358.
139. Antonini D., Russo M.T., De Rosa L., Gorrese M., Del Vecchio L., Missero C. Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. Journal of Investigative Dermatology 2010, 130:1249-1257.
140. Nakamura M., Tokura Y. Epithelial-mesenchymal transition in the skin. Journal of Dermatological Science 2011, 61:7-13.
141. Hu S.J., Ren G., Liu J.L., Zhao Z.A., Yu Y.S., Su R.W., et al. MicroRNA expression and regulation in mouse uterus during embryo implantation. Journal of Biological Chemistry 2008, 283:23473-23484.
142. Su R.W., Lei W., Liu J.L., Zhang Z.R., Jia B., Feng X.H., et al. The integrative analysis of microRNA and mRNA expression in mouse uterus under delayed implantation and activation. PLoS ONE 2010, 5:e15513.
143. Maccani M.A., Avissar-Whiting M., Banister C.E., McGonnigal B., Padbury J.F., Marsit C.J. Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics 2010, 5:583-589.
144. Maccani M.A., Padbury J.F., Marsit C.J. miR-16 and miR-21 expression in the placenta is associated with fetal growth. PLoS ONE 2011, 6:e21210.
145. Mondou E., Dufort I., Gohin M., Fournier E., Sirard M.A. Analysis of microRNAs and their precursors in bovine early embryonic development. Molecular Human Reproduction 2012, 18:425-434.
146. Huang Z.P., Chen J.F., Regan J.N., Maguire C.T., Tang R.H., Dong X.R., et al. Loss of microRNAs in neural crest leads to cardiovascular syndromes resembling human congenital heart defects. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:2575-2586.
147. Hayashi T., Koyama N., Azuma Y., Kashimata M. Mesenchymal miR-21 regulates branching morphogenesis in murine submandibular gland in vitro. Developmental Biology 2011, 352:299-307.
148. Pineles B.L., Romero R., Montenegro D., Tarca A.L., Han Y.M., Kim Y.M., et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. American Journal of Obstetrics and Gynecology 2007, 196. p. 261 e1-261 e6.
149. Zhu X.M., Han T., Sargent I.L., Yin G.W., Yao Y.Q. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs. normal pregnancies. American Journal of Obstetrics and Gynecology 2009, 200. p. 661 e1-661 e7.
150. Mayor-Lynn K., Toloubeydokhti T., Cruz A.C., Chegini N. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reproductive Sciences 2011, 18:46-56.
151. Enquobahrie D.A., Abetew D.F., Sorensen T.K., Willoughby D., Chidambaram K., Williams M.A. Placental microRNA expression in pregnancies complicated by preeclampsia. American Journal of Obstetrics and Gynecology 2011, 204. p. 178 e12-178 e21.
152. Zhang Y., Fei M., Xue G., Zhou Q., Jia Y., Li L., et al. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. Journal of Cellular and Molecular Medicine 2012, 16:249-259.
153. Kane N.M., Meloni M., Spencer H.L., Craig M.A., Strehl R., Milligan G., et al. Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:1389-1397.
154. Alaiti M.A., Ishikawa M., Masuda H., Simon D.I., Jain M.K., Asahara T., et al. Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis. Journal of Cellular and Molecular Medicine 2012, 16:2413-2421.
155. Bianchi N., Zuccato C., Lampronti I., Borgatti M., Gambari R. Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression. BMB Reports 2009, 42:493-499.
156. Bianchi N., Zuccato C., Finotti A., Lampronti I., Borgatti M., Gambari R. Involvement of miRNA in erythroid differentiation. Epigenomics 2012, 4:51-65.
157. Nie Y., Han B.M., Liu X.B., Yang J.J., Wang F., Cong X.F., et al. Identification of MicroRNAs involved in hypoxia- and serum deprivation-induced apoptosis in mesenchymal stem cells. International Journal of Biological Sciences 2011, 7:762-768.
158. Kim H.W., Mallick F., Durrani S., Ashraf M., Jiang S., Haider K.H. Concomitant activation of miR-107/PDCD10 and hypoxamir-210/Casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells. Antioxidants and Redox Signalling 2012, 17:1053-1065.
159. Kim H.W., Jiang S., Ashraf M., Haider K.H. Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function. Journal of Molecular and Medicine (Berlin) 2012, 90:997-1010.
160. Liu Z.H., Yang G., Zhao T., Cao G.J., Xiong L., Xia W., et al. Small ncRNA expression and regulation under hypoxia in neural progenitor cells. Cellular and Molecular Neurobiology 2011, 31:1-5.
161. Singh S.K., Kagalwala M.N., Parker-Thornburg J., Adams H., Majumder S. REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 2008, 453:223-227.
162. Niu Z., Goodyear S.M., Rao S., Wu X., Tobias J.W., Avarbock M.R., et al. MicroRNA-21 regulates the self-renewal of mouse spermatogonial stem cells. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:12740-12745.
163. Kim Y.J., Hwang S.J., Bae Y.C., Jung J.S. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 2009, 27:3093-3102.
164. Kim Y.J., Hwang S.H., Cho H.H., Shin K.K., Bae Y.C., Jung J.S. MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues. Journal of Cellular Physiology 2012, 227:183-193.
165. Bao B., Wang Z., Ali S., Kong D., Li Y., Ahmad A., et al. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Letters 2011, 307:26-36.
166. Ng R., Song G., Roll G.R., Frandsen N.M., Willenbring H. A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. Journal of Clinical Investigation 2012, 122:1097-1108.
167. Sen C.K. Wound healing essentials: let there be oxygen. Wound Repair and Regeneration 2009, 17:1-18.
168. Liu X., Cheng Y., Yang J., Xu L., Zhang C. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. Journal of Molecular and Cellular Cardiology 2012, 52:245-255.
169. Pullen T.J., da Silva Xavier G., Kelsey G., Rutter G.A. miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Molecular and Cellular Biology 2011, 31:3182-3194.
170. Schneider M., Andersen D.C., Silahtaroglu A., Lyngbaek S., Kauppinen S., Hansen J.L., et al. Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry. Journal of Molecular Histology 2011, 42:289-299.
171. Calissano M., Latchman D.S. Cell-specific regulation of the pro-survival Brn-3b transcription factor by microRNAs. Molecular and Cellular Neurosciences 2010, 45:317-323.
172. Judson R.L., Babiarz J.E., Venere M., Blelloch R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nature Biotechnology 2009, 27:459-461.
173. Neilsen C.T., Goodall G.J., Bracken C.P. IsomiRs-the overlooked repertoire in the dynamic microRNAome. Trends in Genetics 2012, 28:544-549.
174. Tsuchiya S., Fujiwara T., Sato F., Shimada Y., Tanaka E., Sakai Y., et al. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). Journal of Biological Chemistry 2011, 286:420-428.
175. Mohankumar K.M., Xu X.Q., Zhu T., Kannan N., Miller L.D., Liu E.T., et al. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells. Oncogene 2007, 26:3998-4008.
176. Muralimanoharan S., Maloyan A., Mele J., Guo C., Myatt L.G., Myatt L. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 2012.
177. Fasanaro P., Greco S., Ivan M., Capogrossi M.C., Martelli F. microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacology and Therapeutics 2010, 125:92-104.
178. Wang T., Zhang L., Shi C., Sun H., Wang J., Li R., et al. TGF-beta-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-beta in HaCaT cells. International Journal of Biochemistry and Cell Biology 2012, 44:366-376.
179. Yang X., Wang J., Guo S.L., Fan K.J., Li J., Wang Y.L., et al. miR-21 promotes keratinocyte migration and re-epithelialization during wound healing. International Journal of Biological Sciences 2011, 7:685-690.
180. Sen C.K., Roy S. MicroRNA 21 in tissue injury and inflammation. Cardiovascular Research 2012, 96:230-233.
181. Roy S., Khanna S., Hussain S.R., Biswas S., Azad A., Rink C., et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovascular Research 2009, 82:21-29.
182. Kumarswamy R., Volkmann I., Jazbutyte V., Dangwal S., Park D.H., Thum T. Transforming growth factor-beta-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21. Arteriosclerosis, Thrombosis, and Vascular Biology 2012, 32:361-369.
183. Zhu H., Li Y., Qu S., Luo H., Zhou Y., Wang Y., et al. MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. Journal of Clinical Immunology 2012, 32:514-522.